Detalles de la búsqueda
1.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Ann Oncol
; 33(12): 1250-1268, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228963
2.
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population.
Ann Oncol
; 30(5): 774-780, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30860570
3.
Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
ESMO Open
; 6(1): 100005, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33399072
4.
Lockdown lessons: The virtual cleft multidisciplinary clinic.
J Plast Reconstr Aesthet Surg
; 74(8): 1931-1971, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140242
5.
Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005].
ESMO Open
; 6(2): 100056, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545518
6.
A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition.
Eur J Cancer
; 51(18): 2725-31, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597446
7.
Vaccines in oncology: background and clinical potential.
Br J Radiol
; 74(887): 991-1002, 2001 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-11709463
8.
Science, medicine, and the future: Cellular immunotherapy for cancer.
BMJ
; 323(7324): 1289-93, 2001 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11731394
Resultados
1 -
8
de 8
1
Próxima >
>>